What is the recommended concentration of tranexamic acid (TXA) for rapid intravenous or intra‑osseous administration in a combat environment?

TXA Concentration for Combat Environment

For rapid IV or IO administration in combat, use 1 gram TXA in 10 mL (100 mg/mL concentration) administered as a slow push or infusion over 10 minutes, followed by a second 1 gram dose over 8 hours if feasible. Alternatively, a simplified 2 gram dose can be given as a single slow push when the maintenance infusion is not practical in austere environments 1, 2.

Recommended Concentration and Dosing

The standard concentration is 100 mg/mL (1 gram in 10 mL) 3, 4. This concentration allows for:

• Initial bolus: 1 gram IV/IO over 10 minutes (infuse no faster than 1 mL/minute to avoid hypotension)
• Maintenance: 1 gram IV/IO over 8 hours if hospital transfer is imminent
• Simplified combat dosing: 2 gram total dose as slow push when maintenance infusion is impractical 2, 5

Route-Specific Considerations for Combat

Intravenous/Intraosseous routes are preferred and achieve equivalent pharmacokinetics 6. The IO route reaches peak concentrations comparable to IV (Cmax similar between routes, p=0.005 vs IM) and should be used when IV access is difficult 6.

Intramuscular administration is a viable backup option when IV/IO access is impossible 5, 7, 6. While IM achieves only 39% of IV peak concentration, it demonstrates 120% bioavailability with prolonged therapeutic levels 6, 8. The same 100 mg/mL concentration can be used, though larger volumes (10 mL for 1 gram) require injection into large muscle groups 7.

Critical Timing Window

Administer within 90 minutes of injury for maximum mortality benefit, and no later than 3 hours post-injury 1, 2, 9. The median time to administration in deployed settings is 44 minutes 5. Earlier administration correlates with 65% lower 30-day mortality (HR 0.35,95% CI 0.19-0.65) 1.

Practical Combat Considerations

• Point-of-injury administration: 46% of combat casualties receive TXA at point of injury, with 38% receiving it en route 5
• Dilution: Can be mixed with electrolyte solutions, carbohydrate solutions, amino acids, or Dextran. Do NOT mix with blood or penicillin-containing solutions 3
• Infusion rate: Maximum 1 mL/minute to prevent hypotension 3, 4
• Storage: Diluted mixture stable for 4 hours at room temperature 3

Dosing Algorithm for Combat

1. Hemorrhagic shock present (tachycardia, hypotension, altered mental status):

   • Give 1 gram (10 mL of 100 mg/mL) IV/IO over 10 minutes
   • If evacuation >8 hours: add 1 gram maintenance over 8 hours
   • If immediate evacuation or maintenance infusion impractical: give 2 gram total dose as slow push 2, 5

2. IV/IO access unavailable:

   • Give 1 gram (10 mL) IM into large muscle group (vastus lateralis or ventrogluteal preferred for 5+ mL volumes) 7

3. Beyond 3 hours post-injury: Do not administer—no mortality benefit and increased thrombotic risk 1, 2, 9

Safety Considerations

The thromboembolic risk increases significantly at doses ≥4 grams (HR 5.33,95% CI 1.94-14.63) 9. The 1-2 gram dosing range maintains favorable benefit-to-risk ratio in hemorrhagic shock 9. Document administration clearly to prevent duplicate dosing at receiving facilities 2.

Evidence Strength

This recommendation is Grade 1A from the 2023 European Trauma Guidelines 1, supported by the CRASH-2 trial showing 1.5% absolute mortality reduction and one-third reduction in bleeding deaths. The 2025 joint position statement from NAEMSP, ACEP, and ACS-COT confirms these recommendations for prehospital use 2.